Literature DB >> 22089716

Biologic therapies for chronic plaque psoriasis and cardiovascular events.

Thrasivoulos Tzellos, Athanassios Kyrgidis, Konstantinos Toulis.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2011        PMID： 22089716     DOI： 10.1001/jama.2011.1660

Source DB:  PubMed          Journal:  JAMA        ISSN： 0098-7484            Impact factor:   56.272


× No keyword cloud information.
  3 in total

Review 1.  Psoriasis, Cardiovascular Events, and Biologics: Lights and Shadows.

Authors:  Giuseppina Caiazzo; Gabriella Fabbrocini; Roberta Di Caprio; Annunziata Raimondo; Emanuele Scala; Nicola Balato; Anna Balato
Journal:  Front Immunol       Date:  2018-08-13       Impact factor: 7.561

2.  Psoriasis Increased the Risk of Adverse Cardiovascular Outcomes: A New Systematic Review and Meta-Analysis of Cohort Study.

Authors:  Lu Liu; Saijin Cui; Meitong Liu; Xiangran Huo; Guoqiang Zhang; Na Wang
Journal:  Front Cardiovasc Med       Date:  2022-03-25

3.  Association of ustekinumab and briakinumab with major adverse cardiovascular events: An appraisal of meta-analyses and industry sponsored pooled analyses to date.

Authors:  Thrasivoulos Tzellos; Athanassios Kyrgidis; Anastasia Trigoni; Christos C Zouboulis
Journal:  Dermatoendocrinol       Date:  2012-07-01
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.